HUBRO THERAPEUTICS
HUBRO THERAPEUTICS
Website Url:
http://www.hubrotherapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Official Site Inspections
http://www.hubrotherapeutics.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hubro Therapeutics"
Hubro Therapeutics - Crunchbase Company Profile
Ubro Therapeutics’ vaccines induce cancer specific T cells. Search Crunchbase. Start Free TrialSee details»
Hubro Therapeutics - Craft
Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for treating cancer. It develops target mutations, lead candidates, and …See details»
Hubro Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Hubro Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Www.hubrotherapeutics.com. Holding Company | 2018 | Norway | www.hubrotherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
Hubro Therapeutics Overview | SignalHire Company Profile
Organization Website: hubrotherapeutics.com : Hubro Therapeutics industries Biotech: Headquarters Location: Ullernchausséen 64, Oslo, 0379 NO Ullernchausséen 64, Oslo, 0...See details»
Hubro Therapeutics - VentureRadar
Hubro Therapeutics is a privately held biopharmaceutical company devoted to the development and commercialization of novel proprietary therapeutic... ... Find out ...See details»
Hubro Therapeutics AS - Overview - aiHit
Www.hubrotherapeutics.com; [email protected]; 41541-019-0103; biopharmaceutical; CLICK HERE TO SEE DETAILS OF COMPANY CHANGES. Is a privately held …See details»
Hubro Therapeutics Headquarters and Office Locations - Craft
Hubro Therapeutics is headquartered in Oslo, red building , 4 th floor ullernchausseen 64, Norway, and has 1 office location.See details»
Hubro Therapeutics AS Company Profile - Dun & Bradstreet
Hubro Therapeutics AS Company Profile | OSLO, OSLO, Norway | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Hubro Therapeutics - Products, Competitors, Financials, Employees ...
Hubro Therapeutics is a biopharmaceutical company focused on the development and commercialization of cancer vaccines. Use the CB Insights Platform to explore Hubro …See details»
Hubro Therapeutics - Overview, News & Similar companies
View Hubro Therapeutics (www.hubrotherapeutics.com) location in Oslo, Norway , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Hubro Therapeutics Information - RocketReach
Hubrotherapeutics.com; 2 479544XXXX; 473555XXXX; View Similar People. Related Companies NEXT Biometrics. 38 $11m Smartfish. 16 $2m Nordic Trustee. 69 $5.7m Integrated Detector …See details»
Hubro Therapeutics - Company Profile - Tracxn
Nov 30, 2024 Hubro Therapeutics - Developer of immunotherapies for cancer treatment. Raised a total funding of $164K over 1 round from 3 investors. Hubro Therapeutics has 2856 …See details»
Hubro Therapeutics AS - 921 833 016 - Oslo - Proff
Mar 7, 2024 Proff.no gir deg bedriftsinformasjon om Hubro Therapeutics AS, 921 833 016. Finn kontaktinfo, regnskapstall, ledelse, styre og eiere og kunngjøringer.See details»
hubrotherapeutics.com - Hubro Therapeutics - Hubro The.
Hubrotherapeutics.com most likely does not offer any adult content. Popular pages. Hubro Therapeutics - Hubro. Is a privately held biopharmaceutical company devoted to the …See details»
Hubro Therapeutics CEO and Key Executive Team | Craft.co
Hubro Therapeutics's Chief Executive Officer is Jon Amund Eriksen. Other executives include Sarah J. Arbe-Barnes, Chief Operational Officer; Robert M. Miller, Chief Medical Officer and 5 …See details»
Hubro Therapeutics AS raised NOK 7.15 million - Nordic 9
Jun 30, 2019 Hubro Therapeutics AS raised NOK 7.15 million. Hubro Therapeutics AS, an Oslo, Norway-based company that develops immunotherapies for treatment of cancer, announced …See details»
Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from …
Hubro acquires the GM-CSF project from Targovax for a cash payment of NOK10m Hubro will continue the development of GM-CSF as adjuvant for use with its pipeline of novel cancer …See details»
Hubro Therapeutics AS (Hubro Therapeutics AS) - 药物管线_专利_ …
了解Hubro Therapeutics AS (Hubro Therapeutics AS)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 2篇新闻，疾病领域:肿瘤，技术平台:治疗性疫苗，合成肽疫苗，重组多 …See details»
Hubro Therapeutics buys vaccine adjuvant from Targovax
Nov 17, 2022 Norwegian biotech company Targovax is in full swing with preparations for phase II studies with the drug candidate ONCOS-102. Following this spring’s collaboration …See details»